MRK

133.7200.69%
DE

Dalton E. Smart

Senior VP of Finance, Principal Accounting Officer & Global Controller

Mr. Dalton E. Smart, III, has been a Director of Terns Pharmaceuticals, Inc. since May 4, 2026. He is Director of Cidara Therapeutics, Inc. from January 7, 2026. Mr. Smart serves as Senior Vice President of Finance, Principal Accounting Officer & Global Controller at Merck & Co. Inc. since December 04, 2023. He served as Assistant Controller of the Merck & Co. Inc. since September 2023 until December 2023. Prior to his appointment as Assistant Controller, he served the as Vice President – Internal Audit from March 2015 to August 2023 and Executive Director, Audit from November 2009 to February 2015.

Positions